Clinical Trial Update: Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating paclitaxel in combination with liposomal doxorubicin for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Claudia Lorenz-Schlüter | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED